Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019056-13-000425)

Filing Details

Accession Number:: 0001019056-13-000425
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-22 15:39:16
Reporting Period:: 2010-03-12

Filing Date:: 2013-03-22
Accepted Time:: 2013-03-22 15:39:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920465	La Jolla Pharmaceutical Co	LJPC	Biological Products, (No Disgnostic Substances) (2836)	330361285

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1572691	Richard Reinisch	4 Barrett Woods Ballwin MO 63021		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
La Jolla Pharmaceutical Company	Acquisiton	2010-03-12	20	$936.20	20	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2012-07-23	234,000	$0.08	234,020	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2012-07-24	144,780	$0.09	378,800	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2012-07-25	121,200	$0.09	500,000	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2012-08-01	279,305	$0.10	779,305	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2012-08-02	220,695	$0.10	1,000,000	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2013-03-19	80,000	$0.09	1,080,000	No	4	P	Direct
La Jolla Pharmaceutical Company	Acquisiton	2013-03-19	20,000	$0.09	1,100,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct